The difficulty in defining the true high-risk smoldering myeloma
Early intervention trials have been initiated for the precursor disease smoldering myeloma (SMM). A recent study showed that genomic complexity varies widely among patients treated for high-risk SMM and is associated with response to triplet therapy, suggesting that established clinical risk scores...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
1 October 2024
|
| In: |
Clinical cancer research
Year: 2024, Volume: 30, Issue: 19, Pages: 4263-4265 |
| ISSN: | 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-24-1382 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1158/1078-0432.CCR-24-1382 Verlag, lizenzpflichtig, Volltext: https://aacrjournals.org/clincancerres/article-abstract/30/19/4263/748542 |
| Author Notes: | Niels Weinhold, Leo Rasche |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1923377868 | ||
| 003 | DE-627 | ||
| 005 | 20250717010832.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250422s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1158/1078-0432.CCR-24-1382 |2 doi | |
| 035 | |a (DE-627)1923377868 | ||
| 035 | |a (DE-599)KXP1923377868 | ||
| 035 | |a (OCoLC)1528044768 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Weinhold, Niels |e VerfasserIn |0 (DE-588)141225688 |0 (DE-627)626149576 |0 (DE-576)322607388 |4 aut | |
| 245 | 1 | 4 | |a The difficulty in defining the true high-risk smoldering myeloma |c Niels Weinhold, Leo Rasche |
| 264 | 1 | |c 1 October 2024 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 22.04.2025 | ||
| 520 | |a Early intervention trials have been initiated for the precursor disease smoldering myeloma (SMM). A recent study showed that genomic complexity varies widely among patients treated for high-risk SMM and is associated with response to triplet therapy, suggesting that established clinical risk scores often fail to discriminate between stable and aggressive disease.See related article by Kazandjian et al., p. 4482 | ||
| 700 | 1 | |a Rasche, Leo |d 1980- |e VerfasserIn |0 (DE-588)138509298 |0 (DE-627)603782507 |0 (DE-576)307868362 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical cancer research |d Philadelphia, Pa. [u.a.] : AACR, 1995 |g 30(2024), 19 vom: Okt., Seite 4263-4265 |h Online-Ressource |w (DE-627)325489971 |w (DE-600)2036787-9 |w (DE-576)094502234 |x 1557-3265 |7 nnas |a The difficulty in defining the true high-risk smoldering myeloma |
| 773 | 1 | 8 | |g volume:30 |g year:2024 |g number:19 |g month:10 |g pages:4263-4265 |g extent:3 |a The difficulty in defining the true high-risk smoldering myeloma |
| 856 | 4 | 0 | |u https://doi.org/10.1158/1078-0432.CCR-24-1382 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://aacrjournals.org/clincancerres/article-abstract/30/19/4263/748542 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250422 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 141225688 |a Weinhold, Niels |m 141225688:Weinhold, Niels |d 910000 |d 910100 |d 50000 |e 910000PW141225688 |e 910100PW141225688 |e 50000PW141225688 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1923377868 |e 4707929893 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Weinhold","display":"Weinhold, Niels","role":"aut","given":"Niels"},{"given":"Leo","role":"aut","family":"Rasche","display":"Rasche, Leo"}],"language":["eng"],"title":[{"title":"The difficulty in defining the true high-risk smoldering myeloma","title_sort":"difficulty in defining the true high-risk smoldering myeloma"}],"note":["Gesehen am 22.04.2025"],"origin":[{"dateIssuedDisp":"1 October 2024","dateIssuedKey":"2024"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"3 S."}],"name":{"displayForm":["Niels Weinhold, Leo Rasche"]},"recId":"1923377868","relHost":[{"id":{"eki":["325489971"],"issn":["1557-3265"],"zdb":["2036787-9"]},"recId":"325489971","physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["American Association for Cancer Research"]},"disp":"The difficulty in defining the true high-risk smoldering myelomaClinical cancer research","type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"Clinical cancer research","title":"Clinical cancer research"}],"origin":[{"publisherPlace":"Philadelphia, Pa. [u.a.]","publisher":"AACR","dateIssuedKey":"1995","dateIssuedDisp":"1995-"}],"pubHistory":["1.1995 -"],"note":["Gesehen am 08.06.2023","Fortsetzung der Druck-Ausgabe"],"part":{"volume":"30","extent":"3","pages":"4263-4265","year":"2024","text":"30(2024), 19 vom: Okt., Seite 4263-4265","issue":"19"},"language":["eng"],"corporate":[{"display":"American Association for Cancer Research","role":"isb"}]}],"id":{"doi":["10.1158/1078-0432.CCR-24-1382"],"eki":["1923377868"]}} | ||
| SRT | |a WEINHOLDNIDIFFICULTY1202 | ||